A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.
about
Chronic radiation proctitis: tricks to prevent and treatFiducial markers and spacers in prostate radiotherapy: current applicationsRetreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy?Implanted spacer approaches for pelvic radiation therapy.Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from "Challenges and Chances in Prostate Cancer Research Meeting 2013".Systematic review: anal and rectal changes after radiotherapy for prostate cancer.Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.PEG spacer gel and adaptive planning vs single plan in external prostate radiotherapy--clinical dosimetry evaluationProstate Cancer Radiation Therapy: What Do Clinicians Have to Know?Evolution of advanced technologies in prostate cancer radiotherapy.A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers.Rectal protection in prostate stereotactic radiotherapy: a retrospective exploratory analysis of two rectal displacement devices.Spacer application for prostate cancer radiation therapy.ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial.Interdisciplinary consensus statement on indication and application of a hydrogel spacer for prostate radiotherapy based on experience in more than 250 patients.Previous radiation for prostate neoplasm alters surgical and oncologic outcomes after rectal cancer surgery.Long-term intra-fractional motion of the prostate using hydrogel spacer during Cyberknife® treatment for prostate cancer--a case report.Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: preliminary report of a phase II study.Minimal Rectal Toxicity in the Setting of Comorbid Crohn's Disease Following Prostate Cancer Radiotherapy with a Hydrogel Rectal Spacer.ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.Treatment planning after hydrogel injection during radiotherapy of prostate cancer.[Translational uroradio-oncology].Denonvilliers' space expansion by transperineal injection of hydrogel: implications for focal therapy of prostate cancer.Efficacy of a rectal spacer with prostate SABR - first UK experience.Hydrogel spacers in prostate radiotherapy: a promising approach to decrease rectal toxicity.Hydrogel injection reduces rectal toxicity after radiotherapy for localized prostate cancer.Dynamics of rectal balloon implant shrinkage in prostate VMAT : Influence on anorectal dose and late rectal complication risk.Can a peri-rectal hydrogel spaceOAR programme for prostate cancer intensity-modulated radiotherapy be successfully implemented in a regional setting?Impact of hydrogel spacer injections on interfraction prostate motion during prostate cancer radiotherapy.Validation of rectal sparing throughout the course of proton therapy treatment in prostate cancer patients treated with SpaceOAR®.Rectal dose to prostate cancer patients treated with proton therapy with or without rectal spacer.PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol.Ano-rectal wall dose-surface maps localize the dosimetric benefit of hydrogel rectum spacers in prostate cancer radiotherapy
P2860
Q26801205-24B7D1F5-3ECA-4FEB-B012-6D89CD049F4DQ26828469-2B3FE843-AEFA-4E0C-B162-CC766D8C55E0Q28081451-DB99D9D3-AAFE-413F-828F-E8E06F6EED5FQ30276697-48A6B2AC-76D1-4550-B013-1C82601E0A60Q34528219-92669F34-7BCF-4C27-9DF9-EAE9CB229DC8Q35024218-2AEEC648-A688-4D3F-A098-03AF458CCCE4Q36535570-FF8F15E4-B20F-4BE8-A7E0-C11BDC030EDCQ36550586-8E216167-F171-4999-8CF8-03E8C38042CEQ37578562-3AD73417-5E0B-490C-92A9-F7185E57305DQ38135708-CCE2BBEA-0A2E-4498-93D9-C0A3B9F8A0D5Q38357722-022C4948-4AB0-4CF4-938E-8C1069771A40Q38635368-883B0FD9-01A6-404E-9E21-2F81E65C508BQ39198013-CB5274B6-7125-4FEF-A0B3-35678DB335BFQ39456200-E7B614A1-E70E-4529-8B8F-5323F4111015Q39459690-7AE1D8B2-E8FD-4AB3-A552-37E6F32B3AFDQ41101008-356E816B-6A00-4F2D-80B4-81965231E4CFQ41174318-AFA0BC06-25BC-47C0-B8A3-EFFA9DEE9136Q41816565-946BAF70-E90E-4979-BDFB-2EEF61E836E3Q42127216-A106BBD6-3C05-4719-A012-A51B30F2E63CQ42286892-252ADE40-84F4-42CE-B437-5E77B611B4F7Q43379694-4E7FB5DD-7A0A-4807-A4EF-2E48A5AA21C6Q43410693-71096907-A70C-4ADF-ABF9-2F1966E07BEEQ43825679-7D83BFE1-3E61-4BC0-AD54-06035F8009D8Q46130964-07C99EDD-AE41-40AE-9D40-AB6F05B4EF00Q47226698-3634A24D-E212-432C-A25B-F2FF9D676EB5Q47821798-5B15875A-99E8-4F16-96C7-55C83E253383Q48352941-1DA2AE5D-2E5B-422F-AF96-001D5E6EB499Q50077685-846B8CDA-64ED-4B3F-81CC-400272C57382Q50917060-03EAFC1C-62D4-41AE-9AFD-C7315033FD36Q51551038-1CA8321F-0F2D-4D70-9A76-14565621D2D9Q52948812-B6B72631-CDB0-4520-82D3-744EFDEA1CEBQ55054493-B4253CEE-0462-4AA6-8AAF-05B2C0F861B3Q55233411-1E0CD15D-BA39-4EB3-A380-D758EDC1142CQ59136739-9EACB1BD-C593-4727-9646-C1C2DCF5EB82
P2860
A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A multi-institutional clinical ...... alysis of dosimetric outcomes.
@en
A multi-institutional clinical ...... alysis of dosimetric outcomes.
@nl
type
label
A multi-institutional clinical ...... alysis of dosimetric outcomes.
@en
A multi-institutional clinical ...... alysis of dosimetric outcomes.
@nl
prefLabel
A multi-institutional clinical ...... alysis of dosimetric outcomes.
@en
A multi-institutional clinical ...... alysis of dosimetric outcomes.
@nl
P2093
P2860
P1476
A multi-institutional clinical ...... alysis of dosimetric outcomes.
@en
P2093
Baukelien van Triest
Damien C Weber
Danny Y Song
Eric C Ford
Klaus K Herfarth
Matthias Uhl
Michael J Eble
Michael Pinkawa
Raymond Miralbell
Robin Kalisvaart
P2860
P356
10.1016/J.IJROBP.2012.12.019
P407
P577
2013-02-13T00:00:00Z